Septerna appointed Rajiv Patni as Chief Medical Officer effective August 24, 2026. Dr. Patni joins from Judo Bio, where he served as CEO, and brings over 25 years of experience in biopharmaceutical R&D and regulatory affairs. Septerna is a clinical-stage biotechnology company pioneering GPCR drug discovery.
